![](https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fd1e00ek4ebabms.cloudfront.net%2Fproduction%2Faf49d6bb-6383-4db8-b4d6-b242a0464113.jpg?source=next-article&fit=scale-down&quality=highest&width=700&dpr=1)
Rapid trials prompt deals rush for Chinese ‘super me-too’ drugs
Western drugmakers are striking more deals in China to access “bio-better” treatments for diseases from obesity to cancer, taking advantage of the early data on offer from the country’s faster and more lightly regulated trials. Large pharmaceutical groups …